We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
UK government interpretation of the requirements for labelling e-liquids for Northern Ireland.
General advice on due diligence - electronic cigarettes devices and refill containers.
Sets out opportunities for commissioners and providers to realise community pharmacy’s role in protecting and improving the nation's health.
Personal protective equipment for sale by the Department of Health and Social Care (DHSC) including visors, gowns, aprons and goggles.
How the ‘Written Confirmation’ process operates for active substances manufactured in Great Britain (England, Wales and Scotland).
Guidance on moving medicines by air
Information on the measures in the Health Service Medical Supplies (Costs) Bill.
Information for local authorities in England about the grant, which will support local authorities to deliver routine commissioning of PrEP in 2020 to 2021.
Information for manufacturers on the regulations that apply to prosthetic, orthotic and ophthalmic devices.
Guidance for manufacturers who source their own-branded products from another company.
Information about the types of content published by the MHRA.
Poster with advice for healthcare professionals on how to carry out point of care testing safely and correctly.
Guidance for healthcare professionals on providing free prescriptions for participants in the HEAL-COVID or STIMULATE-ICP long COVID clinical trials.
The findings and recommendations of the Expert Advisory Group on paclitaxel drug-coated balloon catheters and drug-eluting stents which are used to treat patients with peripheral arterial disease.
Confirmation of the regulation 251 of the Human Medicines Regulation following the Brexit transition.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2023.
Patient communication about a very low risk to patient safety in response to the field safety notice (FSN) issued by Diffuplast and MHRA.
A series of webinars providing guidance on the Windsor Framework agreement and the supply of medicines in Northern Ireland.
Guidance for manufacturers of coronary stents. It outlines specific scenarios that should be considered when determining if an incident is reportable.
Update on MHRA UK risk-based GxP inspection programme.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).